Enzalutamide Capsules Exporter from India | Genliva Wellness LLP Oncology Pharma Manufacturer

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP is a trusted Enzalutamide Capsules Manufacturer in India producing advanced hormonal oncology formulations for prostate cancer treatment and androgen-targeted therapy.

Enzalutamide Capsules are widely prescribed for Castration Resistant Prostate Cancer Treatment and metastatic prostate cancer management. The formulation contains Enzalutamide, a potent androgen receptor inhibitor that blocks androgen signaling pathways responsible for the growth and progression of prostate cancer cells.

The company also supplies these formulations as an Androgen Receptor Inhibitor Capsules Exporter and Prostate Cancer Treatment Medicine Supplier for oncology healthcare providers, specialty pharmaceutical distributors, and international cancer care markets.

Enzalutamide Capsules are formulated for androgen-targeted prostate cancer therapy.

Contains Enzalutamide as active ingredient
Androgen receptor inhibitor formulation
Oral oncology capsule dosage form
Designed for advanced prostate cancer treatmen

This formulation is prescribed in oncology treatment management.

Treatment of metastatic prostate cancer
Management of castration-resistant prostate cancer
Used in androgen deprivation therapy protocols
Administered in advanced prostate cancer care
Utilized in hormonal oncology treatment plans
Supports long-term prostate cancer management

Enzalutamide Capsules deliver targeted hormonal therapy for prostate cancer treatment.

Helps inhibit androgen receptor activity
Supports control of prostate cancer progression
Useful in advanced and metastatic disease management
Convenient oral capsule administration